Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients

Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients

Hong Jun Kim,1 Min Jee Jo,2 Bo Ram Kim,2 Jung Lim Kim,2 Yoon A Jeong,2 Yoo Jin Na,2 Seong Hye Park,2 Suk-young Lee,1 Dae-Hee Lee,1,2 Baek-hui Kim,3 Young Do Yoo,4 Sang Cheul Oh1,2 1Division of Oncology and Hematology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Re...

Full description

Bibliographic Details
Main Authors: Kim HJ, Jo MJ, Kim BR, Kim JL, Jeong YA, Na YJ, Park SH, Lee SY, Lee DH, Kim BH, Yoo YD, Oh SC
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:OncoTargets and Therapy
Subjects:
non-small cell lung carcinoma
inflammation
Reactive oxygen species modulator 1
Vascular endothelial growth factor A
reactive oxygen species
Online Access:https://www.dovepress.com/overexpression-of-romo1-is-an-unfavorable-prognostic-biomarker-and-a-p-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/overexpression-of-romo1-is-an-unfavorable-prognostic-biomarker-and-a-p-peer-reviewed-article-OTT

Similar Items